Skip to content
DraconiticResearch
Search Sources API
201,683 studies31 sourcesUpdated 38 min ago
Peer-reviewedCC BYCancers

Pharmacologically Targeting DHODH-Dependent Pyrimidine Metabolism with HSA-Conjugated BRQ Suppresses Leukemogenesis

  • Xiaoxu Zhang1
  • Changhao Tian2
  • Yang Ding2
  • Lei Dong3
  • Jia Yu1
  • Rui Su4
  • Min Gao2
4 affiliations
  1. 1State Key Laboratory of Common Mechanism Research for Major Diseases, Key Laboratory of RNA and Hematopoietic Regulation, Institute of Basic Medical Sciences and School of Basic Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100005, China
  2. 2School of Life Sciences and Health Engineering, Jiangnan University, Wuxi 214122, China
  3. 3Quantitative Biomedical Research Center, Peter O’Donnell Jr. School of Public Health, UT Southwestern Medical Center, Dallas, TX 7539, USA
  4. 4Department of Systems Biology and Center for RNA Biology and Therapeutics, Beckman Research Institute of City of Hope, Monrovia, CA 91010, USA
Read full textPDFCite

Related

  1. Host-pathogen pyrimidine metabolism drives cystic fibrosis lung disease.
    Gaurav Kumar Lohia, Ying-Tsun Chen, Samantha Chen +5
    Nature communicationsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  2. HIF-1α-driven lactate from mesenchymal stem/stromal cells reprograms monocyte metabolism and suppresses autoimmune uveoretinitis
    Hyun Ju Lee, Jung Hwa Ko, Jin Suk Ryu +1
    Cell ReportsPeer-reviewedCC BY 4.0General medicineCrossref
  3. TRPML1 inhibitor ML-SI1 suppresses prostate cancer through dual regulation of androgen receptor and polyamine metabolism
    Jiongzheng Li, Jipeng Ding, Hongfei Wei +6
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. ARHGAP40 suppresses clear cell renal cell carcinoma progression and is associated with altered glutamine-related metabolism and redox balance.
    Na You, Xiaoxia Wang, Caizhu Wang +7
    Cancer biology & therapyPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. CISD1 suppresses COPD inflammation by recruiting ubiquitinated STING and altering macrophage metabolism
    Jiameng Gao, Fengfeng Han, Lili Chen +6
    Respiratory ResearchPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicinePMCDOAJ

Cite

BibTeXRIS
BibTeX
@article{zhang2026pharmacologically,
  title = {{Pharmacologically Targeting DHODH-Dependent Pyrimidine Metabolism with HSA-Conjugated BRQ Suppresses Leukemogenesis}},
  author = {Xiaoxu Zhang and Changhao Tian and Yang Ding and Lei Dong and Jia Yu and Rui Su and Min Gao},
  journal = {Cancers},
  year = {2026},
  month = sep,
  url = {https://europepmc.org/article/PMC/PMC13664278},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Pharmacologically Targeting DHODH-Dependent Pyrimidine Metabolism with HSA-Conjugated BRQ Suppresses Leukemogenesis
AU  - Xiaoxu Zhang
AU  - Changhao Tian
AU  - Yang Ding
AU  - Lei Dong
AU  - Jia Yu
AU  - Rui Su
AU  - Min Gao
PY  - 2026
DA  - 2026/09/23
JO  - Cancers
UR  - https://europepmc.org/article/PMC/PMC13664278
SN  - 2072-6694
ER  -